Extension of preclinical research collaboration agreement with a top-10 large pharma company NewsKristin EivindvikJune 15, 2018
PCI Biotech Holding ASA will be transferred to Oslo Børs from 27.04.2018 NewsKristin EivindvikApril 27, 2018
Publication of prospectus summary for transfer of listing to Oslo Børs NewsKristin EivindvikApril 25, 2018
Exercise of employee share options and resolution to increase the share capital NewsKristin EivindvikApril 12, 2018
Extension of preclinical research collaboration agreement with a top-10 large pharma company NewsKristin EivindvikJanuary 18, 2018
PCI Biotech announces preliminary outcome of meetings with EMA and FDA for development of fimaporfin in inoperable cholangiocarcinoma NewsKristin EivindvikDecember 20, 2017
